Snehal Shah

Director Técnico/Científico/I+D en OCULIS HOLDING AG .

Commercial Services

Consumer Services

Health Technology

Perfil

Snehal Shah currently works at Oculis Holding AG, as President-Research & Development from 2024.
Dr. Shah also formerly worked at Noven Pharmaceuticals, Inc., as Member-Hisamitsu Group from 2012 to 2017, Kyowa Kirin Co., Ltd., as Senior Vice President-Regulatory Affairs from 2017 to 2021, and IVERIC bio, Inc., as SVP, Chief Regulatory & Product Strategy Officer.
Dr. Shah received his doctorate degree from the University of Kansas and undergraduate degree from Rutgers University- Newark.

Cargos activos de Snehal Shah

Empresas	Cargo	Inicio
OCULIS HOLDING AG	Director Técnico/Científico/I+D	10/04/2024

Todos los cargos activos de Snehal Shah

Antiguos cargos conocidos de Snehal Shah.

Empresas	Cargo	Fin
KYOWA KIRIN CO., LTD.	Consejero General	01/01/2021
Noven Pharmaceuticals, Inc. Noven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research, development, manufacture, marketing and sale of transdermal pharmaceutical products	Corporate Officer/Principal	01/01/2017
IVERIC BIO, INC.	Consejero General	-

Ver el detalle de la experiencia de Snehal Shah.

Formación de Snehal Shah.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Snehal Shah.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	6
Noven Pharmaceuticals, Inc. Noven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research, development, manufacture, marketing and sale of transdermal pharmaceutical products	Commercial Services
University of Kansas University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
IVERIC bio, Inc. IVERIC bio, Inc. BiotechnologyHealth Technology Operates as a science-driven biopharmaceutical company that develops novel treatments for retinal diseases	Health Technology
Kyowa Kirin Co., Ltd. Kyowa Kirin Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals; develops biochemical reagents and other chemicals	Health Technology
Rutgers University- Newark Rutgers University- Newark Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Oculis Holding AG Oculis Holding AG Miscellaneous Commercial ServicesCommercial Services Operates as a global biopharmaceutical company that develops novel therapeutics to treat ophthalmic diseases	Commercial Services